Thrombocytopenia differential diagnosis: Difference between revisions
Line 164: | Line 164: | ||
|- | |- | ||
! rowspan="3" align="center" style="background:#DCDCDC;" + |Thrombotic microangiopathy (TMA) | ! rowspan="3" align="center" style="background:#DCDCDC;" + |Thrombotic microangiopathy (TMA) | ||
! align="center" style="background:#DCDCDC;" + |Thrombotic thrombocytopenic purpura (TTP) | ! align="center" style="background:#DCDCDC;" + |[[Thrombotic thrombocytopenic purpura]] ([[Thrombotic thrombocytopenic purpura|TTP]]) | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | - | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 179: | Line 181: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |↓ | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |Fragmented [[Red blood cell|RBC]]<nowiki/>s | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |Nl | |||
| align="center" style="background:#F5F5F5;" + |Nl | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* [[Hemolysis]] | |||
* Microvascular [[thrombosis]] | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Hemolytic uremic syndrome (HUS) | ! align="center" style="background:#DCDCDC;" + |[[Hemolytic-uremic syndrome|Hemolytic uremic syndrome]] ([[Hemolytic-uremic syndrome|HUS]]) | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | - | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 211: | Line 215: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |Nl | |||
| align="center" style="background:#F5F5F5;" + |Nl | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* [[Hemolysis]] | |||
* Microvascular [[thrombosis]] | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |DIC | ! align="center" style="background:#DCDCDC;" + |[[Disseminated intravascular coagulation|DIC]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 241: | Line 245: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |↑↑ | |||
| align="center" style="background:#F5F5F5;" + |↑ | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* [[Hemolysis]] | |||
| | * [[Microvascular disease|Microangiopathy]] | ||
|- | |- | ||
! rowspan="7" align="center" style="background:#DCDCDC;" + |Congenital platelet disorders | ! rowspan="7" align="center" style="background:#DCDCDC;" + |Congenital platelet disorders |
Revision as of 17:25, 15 August 2018
Thrombocytopenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombocytopenia differential diagnosis On the Web |
American Roentgen Ray Society Images of Thrombocytopenia differential diagnosis |
Risk calculators and risk factors for Thrombocytopenia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farbod Zahedi Tajrishi, M.D.
Overview
Thrombocytopenia has a broad range of potential causes. While a good history and physical examination can be helpful to diagnose some of these causes such as drug-induced thrombocytopenia, they usually don't suffice and further evaluation is often needed. There are also some useful points that may guide the physician to an appropriate diagnosis. For example, asymptomatic, isolated thrombocytopenia most probably suggests ITP, while thrombocytopenia in critically ill, hospitalized patients is usually suggestive of iatrogenic causes (eg. dilution), platelet consumption, bone marrow suppression from infection/sepsis, or even drug-induced thrombocytopenia. One should consider however, that a wide variety of other conditions such as autoimmune disorders, nutrient deficiencies, thrombotic microangiopathies could all as well cause thrombocytopenia.
Thrombocytopenia Differential Diagnosis
Differentiating the diseases that can cause thrombocytopenia:
Category | Condition | Mechanism | Mechanism | Inherited | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age range | History | Symptoms | Signs | |||||||||||||||||||||||||
Lab Findings | Imaging | |||||||||||||||||||||||||||
Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | UA | ||||||||||||||||
Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Plt | HB | WBC | |||||||||||||||||||||||
Hematology | Bone marrow disorders | Myelodysplastic syndromes | + | |||||||||||||||||||||||||
Aplastic anemia | + | |||||||||||||||||||||||||||
Acute leukemia | + | |||||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria (PNH) | + | |||||||||||||||||||||||||||
Thrombotic microangiopathy (TMA) | Thrombotic thrombocytopenic purpura (TTP) | + | - | + | ↓ | Fragmented RBCs | Nl | Nl |
| |||||||||||||||||||
Hemolytic uremic syndrome (HUS) | + | - | + | Nl | Nl |
| ||||||||||||||||||||||
DIC | + | - | + | ↑↑ | ↑ | |||||||||||||||||||||||
Congenital platelet disorders | MYH-9 related disorders | + | - | Large platelets | ||||||||||||||||||||||||
Bernard-Soulier syndrome | Absence of
Gp Ib-IX-V |
+ | - | |||||||||||||||||||||||||
Gray platelet syndrome | + | - | ||||||||||||||||||||||||||
Wiskott-Aldrich syndrome | Mutation in GATA-1 | + | - | |||||||||||||||||||||||||
Thrombocytopenia with absent radius (TAR) syndrome | + | - | ||||||||||||||||||||||||||
Alport syndrome | + | - | ||||||||||||||||||||||||||
Von Willebrand disease | + | |||||||||||||||||||||||||||
Nutrient deficiencies | Folate, vitamin B12, copper | + | ||||||||||||||||||||||||||
Category | Condition | Mechanism | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Age range | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings | |
Rheumatologic/autoimmune disorders | ITP |
|
+ | + | - | - | + | Any | - | - | Ecchymoses and | + Mucocutaneous | Nl | - | - | - | ↓↓↓ | Nl | Nl | Nl | Large platelets, otherwise normal | Nl | Nl | Nl | NA | Diagnosis of exclusion | Spontaneous remission | |
Systemic lupus erythematosus (SLE) | + | |||||||||||||||||||||||||||
Antiphospholipid syndrome (APS) | Autoantibody-mediated syndrome | + | ||||||||||||||||||||||||||
Felty's syndrome | Splenomegaly | + | ||||||||||||||||||||||||||
Infection-induced | Bacterial infections | Sepsis | Direct bone marrow suppression | + | + | ↑ | ↑ | |||||||||||||||||||||
Helicobacter pylori | Immune thrombocytopenia | + | ||||||||||||||||||||||||||
Tick-borne infection | + | |||||||||||||||||||||||||||
Viral infections | HIV | An ITP-like condition called primary HIV-associated thrombocytopenia | + | + | + | |||||||||||||||||||||||
Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus | + | |||||||||||||||||||||||||||
Parasitic infections | Malaria | |||||||||||||||||||||||||||
Babesiosis | ||||||||||||||||||||||||||||
Category | Condition | Mechanism | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Age range | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings | |
Medication/toxicity | Antibiotics/ | Occurrence of drug-dependent, platelet-reactive antibodies | + | + | ||||||||||||||||||||||||
Heparin-induced thrombocytopenia | Anti-heparin/PF4 antibody | + | ELISA | Early or delayed-onset | ||||||||||||||||||||||||
Cytotoxic chemotherapy | + | |||||||||||||||||||||||||||
Radiation therapy | Predictable, dose-dependent myelosuppression | + | ||||||||||||||||||||||||||
OTC agents | Quinine-containing beverages | |||||||||||||||||||||||||||
GI | Chronic liver disease | + | ||||||||||||||||||||||||||
Portal hypertension | ||||||||||||||||||||||||||||
Category | Condition | Mechanism | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Age range | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings | |
Vascular | Giant capillary hemangioma | Platelet destruction | + | |||||||||||||||||||||||||
Aortic aneurysm | Platelet destruction | + | ||||||||||||||||||||||||||
Cardiopulmonary bypass | Platelet destruction | + | ||||||||||||||||||||||||||
Other | Alcohol | + | ||||||||||||||||||||||||||
Post-transfusion purpura | Immune mediated platelet destruction | + | ||||||||||||||||||||||||||
Gestational thrombocytopenia | ||||||||||||||||||||||||||||
HELLP syndrome |